Ginger L. Graham

Filings by Ginger L. Graham span 2 companies, the busiest being Genomic Health Inc and Walgreens Boots Alliance, Inc. Over a trading history stretching from 1 January 2016 to 8 November 2019, the count stands at 24 filings.

No open-market sale appears; the market trades are 1 purchase worth €129k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 17 share grants and 4 option exercises.

Most recently, on 14 November 2019, the filings show a transaction in Genomic Health Inc. The most recent open-market purchase was published on 30 October 2017, 3,280 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.